V Square Quantitative Management LLC Has $948,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

V Square Quantitative Management LLC boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 5.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,387 shares of the medical research company’s stock after acquiring an additional 343 shares during the quarter. V Square Quantitative Management LLC’s holdings in Agilent Technologies were worth $948,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of A. Vanguard Group Inc. grew its holdings in shares of Agilent Technologies by 18.2% during the 1st quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock valued at $4,348,471,000 after acquiring an additional 4,605,228 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Agilent Technologies by 13.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock worth $1,242,956,000 after purchasing an additional 1,042,926 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 5.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock worth $1,952,832,000 after purchasing an additional 809,149 shares in the last quarter. Champlain Investment Partners LLC acquired a new stake in shares of Agilent Technologies during the 1st quarter valued at about $61,218,000. Finally, Marshall Wace LLP grew its stake in shares of Agilent Technologies by 48.6% in the 2nd quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company’s stock valued at $124,073,000 after buying an additional 313,155 shares in the last quarter. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares of the company’s stock, valued at $3,650,640. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the sale, the chief executive officer now owns 26,076 shares in the company, valued at $3,650,640. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,953 shares of company stock worth $2,013,630. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Evercore ISI lifted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Barclays upped their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a report on Tuesday. Wolfe Research lowered Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. UBS Group increased their price objective on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Bank of America boosted their target price on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $144.36.

Agilent Technologies Stock Up 1.0 %

A stock opened at $138.83 on Friday. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. The company has a market cap of $40.51 billion, a PE ratio of 32.82, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. The business’s 50-day simple moving average is $141.02 and its 200 day simple moving average is $138.81.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. Agilent Technologies’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.43 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s payout ratio is 22.22%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.